Surgical Automations
- Industry
- Medical Devices
- Founded Year
- 2019
- Headquarters
- Dallas, Texas, USA
- Employee Count
- 4
Key People
-
Sanket Chauhan - Founder & CEO
Email: [emailprotected]
-
Ritambhara Agrawal - Co-Founder & Chief Operating Officer
Email: [emailprotected]
-
Jason Blackstone - Co-Founder
Email: [emailprotected]
Assessment
- Team
-
Aspect: First-time physician innovator
Summary: The founding team comprises first-time entrepreneurs with medical backgrounds.
While the team has strong medical expertise, their lack of prior entrepreneurial experience in MedTech could hinder business growth and investor confidence.
- Clinical Need
-
Aspect: Very Strong
Summary: High demand for autonomous surgical robots in endoscopic procedures.
The increasing complexity and volume of endoscopic procedures necessitate innovative solutions like autonomous surgical robots to enhance precision and efficiency.
- Competition
-
Aspect: Very crowded + Strategics
Summary: Highly competitive market with established players.
The surgical robotics market is dominated by companies like Intuitive Surgical, making market entry and differentiation challenging for new entrants.
- Technical Challenge
-
Aspect: Complex
Summary: Developing autonomous surgical robots involves significant technical complexities.
The integration of AI-based navigation and user-friendly interfaces in surgical robots requires advanced engineering and regulatory compliance, posing substantial challenges.
- Patent
-
Aspect: Applied
Summary: Patent applications filed but not yet granted.
Securing patents is crucial for protecting intellectual property and establishing a unique market position; however, pending status means the protection is not yet in place.
- Financing
-
Aspect: SBIR/SEED
Summary: Early-stage funding secured from accelerators and venture capital.
While early funding indicates investor interest, substantial capital will be required for product development, clinical trials, and market entry.
- Regulatory
-
Aspect: Concept Stage
Summary: Product is in the concept stage with no regulatory approvals.
The company must undergo rigorous clinical trials and obtain FDA approvals, which are time-consuming and resource-intensive processes.
Opportunity Rollup
- Odds of Success
- 4.05
- Peak Market Share
- 6.1
- Segment CAGR
- 10.7%
- Market Segment
- Endoscopy Devices
- Market Sub Segment
- Autonomous Surgical Robots
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.30 |
2 | 0.91 |
3 | 2.13 |
4 | 4.27 |
5 | 6.10 |
Key Takeaway
Surgical Automations addresses a significant clinical need with innovative technology but faces challenges in a competitive market requiring substantial funding and regulatory navigation.